Article Details

AstraZeneca's anti-diabetic drug receives CDSCO approval for patients with chronic kidney ...

Retrieved on: 2022-11-29 08:09:42

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's anti-diabetic drug receives CDSCO approval for patients with chronic kidney .... View article details on HISWAI: https://www.financialexpress.com/healthcare/pharma-healthcare/astrazenecas-anti-diabetic-drug-receives-cdsco-approval-for-patients-with-chronic-kidney-disease-and-heart-failure/2895511/

Excerpt

AstraZeneca's Dapagliflozin is an oral anti-diabetes drug which has shown increasing benefits in not only preventing heart failure but also in ...

Article found on: www.financialexpress.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up